Holder plans sale of 12,192 VYGR shares

A holder of VYGR common stock filed a notice of proposed sale under Rule 144 for 12,192 shares, to be sold through Fidelity Brokerage Services LLC on the NASDAQ, with an aggregate market value of $46,093.08.

Rhea-AI Filing Summary

A holder of VYGR common stock filed a notice of proposed sale under Rule 144 for 12,192 shares, to be sold through Fidelity Brokerage Services LLC on the NASDAQ, with an aggregate market value of $46,093.08. The issuer had 55,600,084 shares outstanding. The shares were acquired on 02/09/2026 through restricted stock vesting as compensation from the issuer.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Form 144 filing disclose for VYGR?

The Form 144 discloses a planned sale of 12,192 VYGR common shares under Rule 144. The shares were recently acquired through restricted stock vesting as compensation and are intended to be sold on the NASDAQ through Fidelity Brokerage Services LLC.

How many VYGR shares are proposed to be sold and at what value?

The filing shows a proposed sale of 12,192 VYGR common shares with an aggregate market value of $46,093.08. This reflects the total market value of the shares covered by this notice at the time the filing details were prepared.

When were the VYGR shares acquired and how were they obtained?

The 12,192 VYGR shares were acquired on 02/09/2026 through restricted stock vesting. The filing identifies the issuer as the source and classifies the vesting as compensation, indicating these shares stem from an equity award rather than an open-market purchase.

On which exchange will the VYGR shares be sold and through which broker?

The notice states that the VYGR common shares are intended to be sold on the NASDAQ. The designated broker for this planned Rule 144 transaction is Fidelity Brokerage Services LLC, based in Smithfield, Rhode Island, as listed in the securities information table.

How many VYGR shares were outstanding when this Form 144 was filed?

The filing reports 55,600,084 VYGR common shares outstanding. This figure provides context for the size of the planned 12,192-share sale relative to the issuer’s total equity base but does not itself represent any new issuance or transaction.

What is the approximate date of sale for the VYGR shares in this Form 144?

The Form 144 lists an approximate date of sale of 02/10/2026 for the 12,192 VYGR common shares. This date reflects when the holder expects to begin selling the securities, subject to market conditions and Rule 144 requirements.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/10/2026 - 04:23 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001577061
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Voyager Therapeutics, Inc.
SEC File Number	001-37625
Address of Issuer	75 HAYDEN AVENUE LEXINGTON MASSACHUSETTS 02421
Phone	857-259-5340
Name of Person for Whose Account the Securities are To Be Sold	Sandrock Alfred
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	12192	46093.08	55600084	02/10/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/09/2026	Restricted Stock Vesting	Issuer			12192	02/09/2026	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks	Sale includes an amount necessary to cover a tax obligation resulting from the settlement of a vested equity award distribution.
Date of Notice	02/10/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Gerardo Ibarra-Munoz, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Alfred W. Sandrock Jr
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)